GlassScriptPhysician profile
Aikaterini Fausnaught
NPI 1841014891
$1,304.99
in general payments reported to CMS, 2019-2025
7 companies · $1,305 in 2025
The $1,305 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $810 · Food and Beverage: $450 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $809.66 |
| Food and Beverage | $450.33 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,085.19 | 2025 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.44 | 2025 | Relistor |
| Valinor Pharma, LLC | $53.32 | 2025 | Movantik |
| Abiomed | $44.64 | 2025 | |
| Collegium Pharmaceutical, INC. | $33.02 | 2025 | Belbuca |
| Bioventus LLC | $16.08 | 2025 | Gelsyn-3 |
| Boston Scientific Corporation | $14.30 | 2025 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aikaterini Fausnaught listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.